Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Supplement for Bipolar Depression Relapse Prevention
NCT03349528Phase 2Active, not recruiting
- Sponsor
- Sheppard Pratt
- Start
- Dec 2018
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar disorder (BD) (2 arms), sponsored by Sheppard Pratt. Primary endpoint: Time to Relapse at 24 weeks. Started Dec 2018; status: active, not recruiting.
02
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT03349528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349528.